Activation of monocytes by three OspA vaccine candidates: Lipoprotein OspA is a potent stimulator of monokines

FEMS Immunology and Medical Microbiology

Volumn 19, Issue 1, 1997, Pages 15-23

  Haupl T ^a   Landgraf, S ^b   Netusil, P ^b   Biller, N ^b   Capiau, C ^c   Desmons, P ^c   Hauser, P ^c   Burmester, G R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Cytokine; Lyme vaccine; OspA

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; OUTER MEMBRANE PROTEIN; VACCINE;

ARTICLE; BORRELIA BURGDORFERI; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYME DISEASE; MONOCYTE; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPROTEINS; LYME DISEASE; MONOCYTES; MONOKINES; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, SYNTHETIC;

EID: 0343329869     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(97)00046-1     Document Type: Article

References (48)

1. Steere, A.C. (1989) Lyme disease. New Engl. J. Med. 321, 586-596.
2. Häupl, T., Hahn, G., Rittig, M., Krause, A., Schoerner, C., Schonherr, U., Kalden, J.R. and Burmester, G.R. (1993) Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 36, 1621-1626.
3. Kimsey, R.B. and Spielman, A. (1990) Motility of Lyme disease spirochetes in fluids as viscous as the extracellular matrix. J. Infect. Dis. 162, 1205-1208.
4. Rittig, M.G., Krause, A., Häupl, T., Schaible, U.E., Modolell, M., Kramer, M.D., Lutjen Drecoll, E., Simon, M.M. and Burmester, G.R. (1992) Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect. Immun. 60, 4205-4212.
5. Rittig, M.G., Häupl, T., Krause, A., Kressel, M., Groscurth, P. and Burmester, G.R. (1994) Borrelia burgdorferi-induced ultrastructural alterations in human phagocytes: a clue to pathogenicity? J. Pathol. 173, 269-282.
6. Rittig, M.G., Häupl, T. and Burmester, G.R. (1994) Coiling phagocytosis: a way for MHC class I presentation of bacterial antigens? Int. Arch. Allergy Immunol. 103, 4-10.
7. de Silva, A.M., Telford, S.R., Brunet, L.R., Barthold, S.W. and Fikrig, E. (1996) Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183, 271-275.
8. Schaible, U.E., Kramer, M.D., Eichmann, K., Modolell, M., Museteanu, C. and Simon, M.M. (1990) Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Natl. Acad. Sci. USA 87, 3768-3772.
9. Fikrig, E., Barthold, S.W., Kantor, F.S. and Flavell, R.A. (1990) Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250, 553-556.
10. Simon, M.M., Schaible, U.E., Kramer, M.D., Eckerskorn, C., Museteanu, C., Muller Hermelink, H.K. and Wallich, R. (1991) Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochaetal infection in mice. J. Infect. Dis. 164, 123-132.
11. Fikrig, E., Barthold, S.W., Marcantonio, N., Deponte, K., Kantor, F.S. and Flavell, R.A. (1992) Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60, 657-661.
12. Fikrig, E., Telford, S.R., Barthold, S.W., Kantor, F.S., Spielman, A. and Flavell, R.A. (1992) Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA 89, 5418-5421.
13. Gern, L., Rais, O., Capiau, C., Hauser, P., Lobet, Y., Simoen, E., Voet, P. and Petre, J. (1994) Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Immunol. Lett. 39, 249-258.
14. Lim, L.C., England, D.M., DuChateau, B.K., Glowacki, N.J., Creson, J.R., Lovrich, S.D., Callister, S.M., Jobe, D.A. and Schell, R.F. (1994) Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect. Immun. 62, 2825-2833.
15. Steere, A.C., Dwyer, E. and Winchester, R. (1990) Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. New Engl. J. Med. 323, 219-223.
16. Lengl Janssen, B., Strauss, A.F., Steere, A.C. and Kamradt, T. (1994) The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J. Exp. Med. 180, 2069-2078.
17. Kamradt, T., Lengl Janssen, B., Strauss, A.F., Bansal, G. and Steere, A.C. (1996) Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. Infect. Immun. 64, 1284-1289.
18. Kamradt, T., Krause, A. and Burmester, G.R. (1995) A role for T cells in the pathogenesis of treatment-resistant Lyme arthritis. Mol. Med. 1, 486-490.
19. Sears, J.E., Fikrig, E., Nakagawa, T.Y., Deponte, K., Marcantonio, N., Kantor, F.S. and Flavell, R.A. (1991) Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J. Immunol. 147, 1995-2000.
20. Shanafelt, M.C., Anzola, J., Soderberg, C., Yssel, H., Turck, C.W. and Peltz, G. (1992) Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. J. Immunol. 148, 218-224.
21. Krause, A., Burmester, G.R., Rensing, A., Schoerner, C., Schaible, U.E., Simon, M.M., Herzer, P., Kramer, M.D. and Wallich, R. (1992) Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J. Clin. Invest. 90, 1077-1084.
22. Dillon, S.B., Demuth, S.G., Schneider, M.A., Weston, C.B., Jones, C.S., Young, J.F., Scott, M., Bhatnaghar, P.K., LoCastro, S. and Hanna, N. (1992) Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine 10, 309-318.
23. Gordon, D.M. (1993) Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens. Vaccine 11, 591-593.
24. Yamada, A., Ziese, M.R., Young, J.F., Yamada, Y.K. and Ennis, F.A. (1985) Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J. Exp. Med. 162, 663-674.
25. Fries, L.F., Dillon, S.B., Hildreth, J.E., Karron, R.A., Funkhouser, A.W., Friedman, C.J., Jones, C.S., Culleton, V.G. and Clements, M.L. (1993) Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. J. Infect. Dis. 167, 593-601.
26. Erdile, L.F., Brandt, M.A., Warakomski, D.J., Westrack, G.J., Sadziene, A., Barbour, A.G. and Mays, J.P. (1993) Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61, 81-90.
27. Schild, H., Deres, K., Wiesmuller, K.H., Jung, G. and Rammensee, H.G. (1991) Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur. J. Immunol. 21, 2649-2654.
28. Bessler, W.G., Suhr, B., Buhring, H.J., Muller, C.P., Wiesmuller, K.H., Becker, G. and Jung, G. (1985) Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant. Immunobiology 170, 239-244.
29. Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S. and Gupta, C.K. (1993) Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 11, 293-306.
30. Hurtenbach, U., Museteanu, C., Gasser, J., Schaible, U.E. and Simon, M.M. (1995) Studies on early events of Borrelia burgdorferi-induced cytokine production in immunodeficient SCID mice by using a tissue chamber model for acute inflammation. Int. J. Exp. Pathol. 76, 111-123.
31. Tai, K.F., Ma, Y. and Weis, J.J. (1994) Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect. Immun. 62, 520-528.
32. Ma, Y. and Weis, J.J. (1993) Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61, 3843-3853.
33. Radolf, J.D., Arndt, L.L., Akins, D.R., Curetty, L.L., Levi, M.E., Shen, Y., Davis, L.S. and Norgard, M.V. (1995) Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154, 2866-2877.
34. Braun, V. (1975) Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim. Biophys. Acta 415, 335-377.
35. Johnson, R.B., Kohl, S. and Bessler, W.G. (1983) Polyclonal activation of B-lymphocytes in vivo by Salmonella typhimurium lipoprotein. Infect. Immun. 39, 1481-1484.
36. Bessler, W.G., Cox, M., Lex, A., Suhr, B., Wiesmuller, K.H. and Jung, G. (1985) Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J. Immunol. 135, 1900-1905.
37. Hoffmann, P., Heinle, S., Schade, U.F., Loppnow, H., Ulmer, A.J., Flad, H.D., Jung, G. and Bessler, W.G. (1988) Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 177, 158-170.
38. Johnson, R.B., Kohl, S., Wiesmuller, K., Jung, G. and Bessler, W.G. (1983) Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo. Immunobiology 165, 27-35.
39. Deres, K., Schild, H., Wiesmuller, K.H., Jung, G. and Rammensee, H.G. (1989) In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342, 561-564.
40. Wolf, B., Uhl, B., Hauschildt, S., Metzger, J., Jung, G. and Bessler, W.G. (1989) Interaction of the lymphoid cell line BCL1 with lipopeptide analogues of bacterial lipoprotein: electron energy loss spectroscopy (EELS) as a novel method to detect the distribution of the activator within the cells. Immunobiology 180, 93-100.
41. Wolf, B., Hauschildt, S., Uhl, B., Metzger, J., Jung, G. and Bessler, W.G. (1989) Localization of the cell activator lipopeptide in bone marrow-derived macrophages by electron energy loss spectroscopy (EELS). Immunol. Lett. 20, 121-126.
42. Wiesmuller, K.H., Jung, G. and Hess, G. (1989) Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 7, 29-33.
43. Chedid, L. (1985) Adjuvants of immunity. Ann. Inst. Pasteur Immunol. 136D, 283-291.
44. Tagliabue, A. and Boraschi, D. (1993) Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171. Vaccine 11, 594-595.
45. Van Hoecke, C., De Grave, D., Hauser, P. and Lebacq, E. (1994) Evaluation of three formulations of a candidate vaccine against Lyme disease in healthy adult volunteers. In: Advances in Lyme Borreliosis: Proceedings of the VI International Conference on Lyme Borreliosis (Cevenini, R., Sambri, V. and La Placa, M., Eds.), pp. 123-126. Esculapio, Bologna.
46. Nocton, J.J., Dressler, F., Rutledge, B.J., Rys, P.N., Persing, D.H. and Steere, A.C. (1994) Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. New Engl. J. Med. 330, 229-234.
47. Fikrig, E., Barthold, S.W. and Flavell, R.A. (1993) OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect. Immun. 61, 2553-2557.
48. Schoen, R.T., Meurice, F., Brunet, C.M., Cretella, S., Krause, D.S., Craft, J.E. and Fikrig, E. (1995) Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease. J. Infect. Dis. 172, 1324-1329.